Hoh B L, Putman C M, Budzik R F, Carter B S, Ogilvy C S
Neurosurgical Service, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
J Neurosurg. 2001 Jul;95(1):24-35. doi: 10.3171/jns.2001.95.1.0024.
Certain intracranial aneurysms, because of their fusiform or complex wide-necked structure, giant size, or involvement with critical perforating or branch vessels. are unamenable to direct surgical clipping or endovascular coil treatment. Management of such lesions requires alternative or novel treatment strategies. Proximal and distal occlusion (trapping) is the most effective strategy. In lesions that cannot be trapped, alteration in blood flow to the "inflow zone," the site most vulnerable to aneurysm growth and rupture, is used.
From 1991 to 1999 the combined neurosurgical-neuroendovascular team at the Massachusetts General Hospital (MGH) managed 48 intracranial aneurysms that could not be clipped or occluded. Intracavernous internal carotid artery aneurysms were excluded from this analysis. By applying a previously described aneurysm rupture risk classification system (MGH Grades 0-5) based on the age of the patient, aneurysm size, Hunt and Hess grade, Fisher grade, and whether the aneurysm was a giant lesion located in the posterior circulation, the authors found that a significant number of patients were at moderate risk (MGH Grade 2; 31.3% of patients) and at high risk (MGH Grades 3 or 4; 22.9%) for treatment-related morbidity. The lesions were treated using a variety of strategies--surgical, endovascular, or a combination of modalities. Aneurysms that could not be trapped or occluded were treated using a paradigm of flow alteration, with flow redirected from either native collateral networks or from a surgically performed vascular bypass. Overall clinical outcomes were determined using the Glasgow Outcome Scale (GOS). A GOS score of 5 or 4 was achieved in 77.1%, a GOS score of 3 or 2 in 8.3%, and death (GOS 1) occurred in 14.6% of the patients. Procedure-related complications occurred in 27.1% of cases; the major morbidity rate was 6.3% and the mortality rate was 10.4%. Three patients experienced aneurysmal hemorrhage posttreatment; in two patients this event proved to be fatal. Aneurysms with MGH Grades 0, 1, 2, 3, and 4 were associated with favorable outcomes (GOS scores of 5 or 4) in 100%, 92.8%, 71.4%, 50%, and 0% of instances, respectively.
Despite a high incidence of transient complications, intracranial aneurysms that cannot be clipped or occluded require alternative surgical and endovascular treatment strategies. In those aneurysms that cannot safely be trapped or occluded, one approach is the treatment strategy of flow alteration.
某些颅内动脉瘤,因其梭形或复杂的宽颈结构、巨大尺寸,或累及关键的穿支血管或分支血管,无法直接进行手术夹闭或血管内栓塞治疗。此类病变的处理需要采用替代或新颖的治疗策略。近端和远端闭塞(夹闭)是最有效的策略。对于无法夹闭的病变,则采用改变流向“流入区”(最易发生动脉瘤生长和破裂的部位)的血流的方法。
1991年至1999年,麻省总医院(MGH)的神经外科 - 神经血管内联合团队处理了48例无法夹闭或栓塞的颅内动脉瘤。本分析排除海绵窦段颈内动脉瘤。通过应用先前描述的基于患者年龄、动脉瘤大小、Hunt和Hess分级、Fisher分级以及动脉瘤是否为位于后循环的巨大病变的动脉瘤破裂风险分类系统(MGH 0 - 5级),作者发现相当数量的患者处于中度风险(MGH 2级;占患者的31.3%)和高风险(MGH 3级或4级;占22.9%),有治疗相关并发症的可能。这些病变采用了多种治疗策略——手术、血管内或联合治疗方式。无法夹闭或栓塞的动脉瘤采用血流改道模式进行治疗,血流可从天然侧支网络或通过手术进行的血管搭桥重新导向。总体临床结局采用格拉斯哥预后量表(GOS)进行评估。77.1%的患者GOS评分为5或4,8.3%的患者GOS评分为3或2,14.6%的患者死亡(GOS 1)。27.1%的病例发生了与手术相关的并发症;主要并发症发生率为6.3%,死亡率为10.4%。3例患者治疗后发生动脉瘤出血;其中2例死亡。MGH 0级、1级、2级、3级和4级的动脉瘤分别在100%、92.8%、71.4%、50%和0%的情况下获得了良好结局(GOS评分为5或4)。
尽管短暂并发症发生率较高,但无法夹闭或栓塞的颅内动脉瘤仍需要采用替代的手术和血管内治疗策略。对于那些无法安全夹闭或栓塞的动脉瘤,一种方法是血流改道的治疗策略。